Lariago 250mg Tablet is an antimalarial medicine containing chloroquine and is used for the treatment or prevention of malaria when chloroquine is an appropriate option. Official Indian pharmaceutical pricing records identify Lariago tablets as chloroquine phosphate products, while U.S. CDC information explains that a 250 mg chloroquine-phosphate tablet corresponds to 150 mg of chloroquine base.

What Is Lariago 250mg Tablet?

Lariago 250mg Tablet contains chloroquine, an antimalarial medicine that interferes with the malaria parasite’s ability to survive inside red blood cells. Doctors may prescribe chloroquine for susceptible malaria infections. However, chloroquine does not work reliably against all malaria parasites because resistance has developed in several regions. Therefore, healthcare professionals should identify the likely malaria species and geographic exposure before selecting treatment.

A particularly important point concerns the strength printed on the package. A 250 mg chloroquine-phosphate tablet represents 150 mg of chloroquine base. Patients should therefore follow the prescribed dose rather than attempting to calculate treatment from the number printed on the tablet alone.

How Does Lariago 250mg Tablet Work?

Chloroquine concentrates within malaria parasites and interferes with their handling of heme, a substance released when the parasite digests hemoglobin. This disruption damages the parasite and helps clear susceptible blood-stage malaria infections.

The medicine works only against susceptible parasites. For example, CDC treatment guidance lists chloroquine phosphate for certain chloroquine-sensitive infections, while recommending different medicines when resistance is expected.

Because malaria can become serious quickly, do not choose an antimalarial solely from the symptoms. Fever, chills, sweating, headache, weakness, nausea, and body aches can occur with malaria but can also occur with other infections.

Uses of Lariago 250mg Tablet

Doctors may use Lariago 250mg Tablet when chloroquine is clinically suitable for malaria. Chloroquine can be used against certain susceptible malaria species, including Plasmodium malariae and susceptible P. vivax or P. ovale infections. Some infections require additional treatment to eliminate dormant liver-stage parasites and prevent relapse.

The medicine should not automatically be considered suitable for P. falciparum malaria because resistance is widespread in many parts of the world. Your healthcare professional can select treatment according to the malaria species, travel history, local resistance patterns, pregnancy status, age, weight, and other medical factors.

Related Product

How Should You Take Lariago 250mg Tablet?

Take Lariago 250mg Tablet exactly as prescribed. Do not increase the dose, repeat doses, or extend treatment because your fever has not immediately disappeared.

Treatment schedules differ according to the patient’s age, body weight, malaria species, and geographic exposure. CDC guidance demonstrates that chloroquine treatment uses a specific loading dose followed by additional doses at defined intervals rather than a simple “one tablet per day” approach.

Take the medicine with water and follow the instructions provided by your prescriber or pharmacist. If you vomit soon after taking a dose, contact a healthcare professional before repeating it.

Important Safety Information

Before taking Lariago 250mg Tablet, tell your healthcare professional about existing medical conditions and all medicines or supplements you use. Chloroquine can interact with other medicines, and certain patients require additional monitoring.

Seek medical advice promptly if you develop significant vision changes, severe weakness, fainting, unusual heartbeat, severe dizziness, confusion, or other serious symptoms. Do not continue self-treatment simply because the medicine was effective during a previous malaria episode.

Patients with eye disorders, liver disease, kidney problems, certain blood disorders, or heart-rhythm concerns should discuss these conditions with a healthcare professional before using chloroquine.

Side Effects of Lariago 250mg Tablet

Some people may experience nausea, stomach discomfort, diarrhea, headache, dizziness, or itching while taking chloroquine. Taking the medicine exactly as directed can help reduce avoidable problems.

More serious reactions require medical attention. Vision problems, significant muscle weakness, abnormal heart rhythm, fainting, severe skin reactions, or neurological symptoms should not be ignored.

Longer-term chloroquine exposure can require particular attention to eye health. Your clinician can determine whether monitoring is necessary based on the duration and reason for treatment.

Who Should Avoid Self-Medicating?

Do not self-diagnose malaria and begin Lariago 250mg Tablet without professional guidance. Malaria can progress to severe disease, and choosing an ineffective antimalarial can delay appropriate treatment.

Pregnant patients, children, older adults, and people with chronic medical conditions should receive individualized advice. The correct dose often depends on body weight, particularly in children.

Frequently Asked Questions

Is Lariago 250mg Tablet an antibiotic?

No. Lariago 250mg Tablet is an antimalarial medicine containing chloroquine. It does not treat ordinary bacterial infections.

Can Lariago 250mg Tablet treat every type of malaria?

No. Chloroquine works only against susceptible malaria parasites. Resistance varies geographically, so a healthcare professional must select appropriate therapy.

Is 250 mg the amount of chloroquine base?

Not necessarily. A 250 mg chloroquine-phosphate tablet corresponds to 150 mg of chloroquine base.

Can I take Lariago 250mg Tablet without a malaria test?

You should not self-treat based only on symptoms. Fever has many causes, and malaria requires appropriate diagnostic evaluation and treatment.

What if I miss a dose?

Follow your prescription instructions and contact your pharmacist or prescriber for specific advice. Do not automatically double the next dose.